investigated, whether Metreleptin administration for 12 months has an impact on the global NASH score in adults with obesity and with relative leptin deficiency (individual leptin level <25th percentile for leptin levels related to age and BMI of a reference group). Here, LEP is linked to metabolic dysfunction-associated steatohepatitis.